Welcome to Co-Pharma Ltd!
Co-pharma Ltd is a small but fast growing pharmaceutical company based in Watford United Kingdom engaged in the acquisition, development, marketing and distribution of a wide range of generic medicines, as well as OTC brands. Growth at Co-pharma Limited is driven by a focus on quality excellence in every aspect of product development, manufacture and distribution.
This quality emphasis has laid a foundation for Co-pharma to grow, from modest beginnings in 1993, to be amongst one of the most reliable suppliers of pharmaceutical products in the UK today, with several NHS contracts and ongoing OLS agreements in place.
Our heritage OTC brands have become the standard for treatment/ usage within their therapeutic segments and also demonstrate continued growth in the retail sector.
Manufacturing of most of our generics is now carried out by our parent company Strides Arcolab Limited at their world class manufacturing plants, based in Bangalore India. www.stridesarco.com
Co-pharma products add value to healthcare systems by providing high quality medicines that are affordable. With a diverse and rapidly growing product range, we cover a number of therapeutic segments.
Over The Counter medicines/ formulations
The Quality Driven Values at Co-pharma has fuelled our growth in recent years, in the challenging environment of generic markets in the UK we continue to grow our OTC brands to supplement this generic activity..
Aquabar™, Vesagex Heelbalm™ Snore No more™ and Aqueous cream, provide additional choice to the pharmacist and the consumer, for relief of common skin ailments and complaints. Swim Ear™ for trapped ear water, Noseeze™ for dry and crusty nasal tissue, and the ever popular Punch and Judy ™ children’s toothpaste provide value additions to help the customer have more informed choices.
Our diverse range of products manufactured by our parent company Strides Arcolabs Limited is a testimony to our commitment to make a positive contribution to the healthcare system. We are constantly evaluating the feasibility of products designed to reduce the cost of manufacturing, while retaining the safety and efficacy of the product molecule. There is a constant endeavour to formulate newer generics and make them available to the health care providers.
Our finished dosage form products, due to our quality driven value system ensures that the product made available to the consumer is of the highest standard of quality and efficacy.
Co-pharma Limited play a small but important role in the UK generic market. It has a diverse product portfolio of 34 molecules, 64 licenses offering over 100 presentations, with more in the pipeline. We are focused on developing/acquiring more generics across the range.
Co-pharma’s wide range of products covers the following therapeutic classes:
- Anti hypertensives
- Anti depressants
- Anti spasmodics